img

Global Saphris (Asenapine) Industry Research Report, Growth Trends and Competitive Analysis 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Saphris (Asenapine) Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

The global Saphris (Asenapine) market size was US$ million in 2022 and is forecast to a readjusted size of US$ million by 2034 with a CAGR of % during the forecast period 2024-2034.
The United States market for Saphris (Asenapine) is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The China market for Saphris (Asenapine) is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The Europe market for Saphris (Asenapine) is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034..
The global key manufacturers of Saphris (Asenapine) include Allergan plc (AbbVie Inc.), Merck & Co., Inc. and Actavis Generics (Teva), etc. In 2022, the global top five players hold a share approximately % in sales volume, and in term of revenue of Saphris (Asenapine), the top five companies hold a share nearly %.
In terms of sales (consumption) side, this report focuses on the sales of Saphris (Asenapine) by regions (Countries), company, by type and by type. from 2018 to 2024 and forecast to 2034.
The global Saphris (Asenapine) market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of sales analysis, the authors of the report have provided reliable estimations and calculations for global revenue and sales by type segment of the global Saphris (Asenapine) market. These figures have been provided in terms of both revenue and sales for the period 2018-2034. Additionally, the report provides accurate figures for sales by region in terms of revenue as well as volume for the same period.



By Company


Allergan plc (AbbVie Inc.)
Merck & Co., Inc.
Actavis Generics (Teva)
By Type
5 mg
10 mg
By Application
Schizophrenia
Acute Mania
Others
Sales by Region
North America
U.S.
Canada
China
APAC (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Sales (consumption), revenue of Saphris (Asenapine) in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3Detailed analysis of Saphris (Asenapine) manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 7Europe by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 8China by company, by type and by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by company, by type, by application and by region, sales, and revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 11Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Saphris (Asenapine) sales, revenue, price, gross margin, and recent development, etc.
Chapter 12Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14The main points and conclusions of the report.

Table of Content

1 Report Overview
1.1 Saphris (Asenapine) Definition
1.2 Market by Type
1.2.1 Global Saphris (Asenapine) Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 5 mg
1.2.3 10 mg
1.3 Market Segment by Application
1.3.1 Global Saphris (Asenapine) Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Schizophrenia
1.3.3 Acute Mania
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Saphris (Asenapine) Sales
2.1 Global Saphris (Asenapine) Revenue Estimates and Forecasts 2018-2034
2.2 Global Saphris (Asenapine) Revenue by Region: 2018 VS 2022 VS 2034
2.3 Global Saphris (Asenapine) Revenue by Region
2.3.1 Global Saphris (Asenapine) Revenue by Region (2018-2024)
2.3.2 Global Saphris (Asenapine) Revenue by Region (2024-2034)
2.4 Global Saphris (Asenapine) Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Saphris (Asenapine) Sales Quantity by Region: 2018 VS 2022 VS 2034
2.6 Global Saphris (Asenapine) Sales Quantity by Region
2.6.1 Global Saphris (Asenapine) Sales Quantity by Region (2018-2024)
2.6.2 Global Saphris (Asenapine) Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Saphris (Asenapine) Sales Quantity by Manufacturers
3.1.1 Global Saphris (Asenapine) Sales Quantity by Manufacturers (2018-2024)
3.1.2 Global Saphris (Asenapine) Sales Quantity Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Companies by Saphris (Asenapine) Sales in 2022
3.2 Global Saphris (Asenapine) Revenue by Manufacturers
3.2.1 Global Saphris (Asenapine) Revenue by Manufacturers (2018-2024)
3.2.2 Global Saphris (Asenapine) Revenue Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Saphris (Asenapine) Revenue in 2022
3.3 Global Saphris (Asenapine) Sales Price by Manufacturers
3.4 Global Key Players of Saphris (Asenapine), Industry Ranking, 2021 VS 2022
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Saphris (Asenapine) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Saphris (Asenapine), Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Saphris (Asenapine), Product Offered and Application
3.8 Global Key Manufacturers of Saphris (Asenapine), Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Saphris (Asenapine) Sales Quantity by Type
4.1.1 Global Saphris (Asenapine) Historical Sales Quantity by Type (2018-2024)
4.1.2 Global Saphris (Asenapine) Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Saphris (Asenapine) Sales Quantity Market Share by Type (2018-2034)
4.2 Global Saphris (Asenapine) Revenue by Type
4.2.1 Global Saphris (Asenapine) Historical Revenue by Type (2018-2024)
4.2.2 Global Saphris (Asenapine) Forecasted Revenue by Type (2024-2034)
4.2.3 Global Saphris (Asenapine) Revenue Market Share by Type (2018-2034)
4.3 Global Saphris (Asenapine) Price by Type
4.3.1 Global Saphris (Asenapine) Price by Type (2018-2024)
4.3.2 Global Saphris (Asenapine) Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Saphris (Asenapine) Sales Quantity by Application
5.1.1 Global Saphris (Asenapine) Historical Sales Quantity by Application (2018-2024)
5.1.2 Global Saphris (Asenapine) Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Saphris (Asenapine) Sales Quantity Market Share by Application (2018-2034)
5.2 Global Saphris (Asenapine) Revenue by Application
5.2.1 Global Saphris (Asenapine) Historical Revenue by Application (2018-2024)
5.2.2 Global Saphris (Asenapine) Forecasted Revenue by Application (2024-2034)
5.2.3 Global Saphris (Asenapine) Revenue Market Share by Application (2018-2034)
5.3 Global Saphris (Asenapine) Price by Application
5.3.1 Global Saphris (Asenapine) Price by Application (2018-2024)
5.3.2 Global Saphris (Asenapine) Price Forecast by Application (2024-2034)
6 North America
6.1 North America Saphris (Asenapine) Sales by Company
6.1.1 North America Saphris (Asenapine) Revenue by Company (2018-2024)
6.1.2 North America Saphris (Asenapine) Sales Quantity by Company (2018-2024)
6.2 North America Saphris (Asenapine) Market Size by Type
6.2.1 North America Saphris (Asenapine) Sales Quantity by Type (2018-2034)
6.2.2 North America Saphris (Asenapine) Revenue by Type (2018-2034)
6.3 North America Saphris (Asenapine) Market Size by Application
6.3.1 North America Saphris (Asenapine) Sales Quantity by Application (2018-2034)
6.3.2 North America Saphris (Asenapine) Revenue by Application (2018-2034)
6.4 North America Saphris (Asenapine) Market Size by Country
6.4.1 North America Saphris (Asenapine) Revenue by Country: 2018 VS 2022 VS 2034
6.4.2 North America Saphris (Asenapine) Revenue by Country (2018-2034)
6.4.3 North America Saphris (Asenapine) Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Saphris (Asenapine) Sales by Company
7.1.1 Europe Saphris (Asenapine) Sales Quantity by Company (2018-2024)
7.1.2 Europe Saphris (Asenapine) Revenue by Company (2018-2024)
7.2 Europe Saphris (Asenapine) Market Size by Type
7.2.1 Europe Saphris (Asenapine) Sales Quantity by Type (2018-2034)
7.2.2 Europe Saphris (Asenapine) Revenue by Type (2018-2034)
7.3 Europe Saphris (Asenapine) Market Size by Application
7.3.1 Europe Saphris (Asenapine) Sales Quantity by Application (2018-2034)
7.3.2 Europe Saphris (Asenapine) Revenue by Application (2018-2034)
7.4 Europe Saphris (Asenapine) Market Size by Country
7.4.1 Europe Saphris (Asenapine) Revenue by Country: 2018 VS 2022 VS 2034
7.4.2 Europe Saphris (Asenapine) Revenue by Country (2018-2034)
7.4.3 Europe Saphris (Asenapine) Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Saphris (Asenapine) Sales by Company
8.1.1 China Saphris (Asenapine) Sales Quantity by Company (2018-2024)
8.1.2 China Saphris (Asenapine) Revenue by Company (2018-2024)
8.2 China Saphris (Asenapine) Market Size by Type
8.2.1 China Saphris (Asenapine) Sales Quantity by Type (2018-2034)
8.2.2 China Saphris (Asenapine) Revenue by Type (2018-2034)
8.3 China Saphris (Asenapine) Market Size by Application
8.3.1 China Saphris (Asenapine) Sales Quantity by Application (2018-2034)
8.3.2 China Saphris (Asenapine) Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Saphris (Asenapine) Sales by Company
9.1.1 APAC Saphris (Asenapine) Sales Quantity by Company (2018-2024)
9.1.2 APAC Saphris (Asenapine) Revenue by Company (2018-2024)
9.2 APAC Saphris (Asenapine) Market Size by Type
9.2.1 APAC Saphris (Asenapine) Sales Quantity by Type (2018-2034)
9.2.2 APAC Saphris (Asenapine) Revenue by Type (2018-2034)
9.3 APAC Saphris (Asenapine) Market Size by Application
9.3.1 APAC Saphris (Asenapine) Sales Quantity by Application (2018-2034)
9.3.2 APAC Saphris (Asenapine) Revenue by Application (2018-2034)
9.4 APAC Saphris (Asenapine) Market Size by Region
9.4.1 APAC Saphris (Asenapine) Revenue by Region: 2018 VS 2022 VS 2034
9.4.2 APAC Saphris (Asenapine) Revenue by Region (2018-2034)
9.4.3 APAC Saphris (Asenapine) Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Saphris (Asenapine) Sales by Company
10.1.1 Middle East, Africa and Latin America Saphris (Asenapine) Sales Quantity by Company (2018-2024)
10.1.2 Middle East, Africa and Latin America Saphris (Asenapine) Revenue by Company (2018-2024)
10.2 Middle East, Africa and Latin America Saphris (Asenapine) Market Size by Type
10.2.1 Middle East, Africa and Latin America Saphris (Asenapine) Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Saphris (Asenapine) Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Saphris (Asenapine) Market Size by Application
10.3.1 Middle East, Africa and Latin America Saphris (Asenapine) Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Saphris (Asenapine) Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Saphris (Asenapine) Market Size by Country
10.4.1 Middle East, Africa and Latin America Saphris (Asenapine) Revenue by Country: 2018 VS 2022 VS 2034
10.4.2 Middle East, Africa and Latin America Saphris (Asenapine) Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Saphris (Asenapine) Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Allergan plc (AbbVie Inc.)
11.1.1 Allergan plc (AbbVie Inc.) Company Information
11.1.2 Allergan plc (AbbVie Inc.) Overview
11.1.3 Allergan plc (AbbVie Inc.) Saphris (Asenapine) Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.1.4 Allergan plc (AbbVie Inc.) Saphris (Asenapine) Products and Services
11.1.5 Allergan plc (AbbVie Inc.) Saphris (Asenapine) SWOT Analysis
11.1.6 Allergan plc (AbbVie Inc.) Recent Developments
11.2 Merck & Co., Inc.
11.2.1 Merck & Co., Inc. Company Information
11.2.2 Merck & Co., Inc. Overview
11.2.3 Merck & Co., Inc. Saphris (Asenapine) Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.2.4 Merck & Co., Inc. Saphris (Asenapine) Products and Services
11.2.5 Merck & Co., Inc. Saphris (Asenapine) SWOT Analysis
11.2.6 Merck & Co., Inc. Recent Developments
11.3 Actavis Generics (Teva)
11.3.1 Actavis Generics (Teva) Company Information
11.3.2 Actavis Generics (Teva) Overview
11.3.3 Actavis Generics (Teva) Saphris (Asenapine) Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.3.4 Actavis Generics (Teva) Saphris (Asenapine) Products and Services
11.3.5 Actavis Generics (Teva) Saphris (Asenapine) SWOT Analysis
11.3.6 Actavis Generics (Teva) Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Saphris (Asenapine) Value Chain Analysis
12.2 Saphris (Asenapine) Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Saphris (Asenapine) Production Mode & Process
12.4 Saphris (Asenapine) Sales and Marketing
12.4.1 Saphris (Asenapine) Sales Channels
12.4.2 Saphris (Asenapine) Distributors
12.5 Saphris (Asenapine) Customers
13 Market Dynamics
13.1 Saphris (Asenapine) Industry Trends
13.2 Saphris (Asenapine) Market Drivers
13.3 Saphris (Asenapine) Market Challenges
13.4 Saphris (Asenapine) Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Saphris (Asenapine) Market Size Growth Rate (CAGR) by Type, 2018 VS 2022 VS 2034 (US$ Million)
Table 2. Major Manufacturers of 5 mg
Table 3. Major Manufacturers of 10 mg
Table 4. Global Saphris (Asenapine) Market Size Growth Rate (CAGR) by Application, 2018 VS 2022 VS 2034 (US$ Million)
Table 5. Global Saphris (Asenapine) Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 6. Global Saphris (Asenapine) Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Saphris (Asenapine) Revenue Market Share by Region (2018-2024)
Table 8. Global Saphris (Asenapine) Revenue by Region (2024-2034) & (US$ Million)
Table 9. Global Saphris (Asenapine) Revenue Market Share by Region (2024-2034)
Table 10. Global Saphris (Asenapine) Sales Quantity by Region: 2018 VS 2022 VS 2034 (K Units)
Table 11. Global Saphris (Asenapine) Sales by Region (2018-2024) & (K Units)
Table 12. Global Saphris (Asenapine) Sales Market Share by Region (2018-2024)
Table 13. Global Saphris (Asenapine) Sales by Region (2024-2034) & (K Units)
Table 14. Global Saphris (Asenapine) Sales Market Share by Region (2024-2034)
Table 15. Global Saphris (Asenapine) Sales Quantity by Manufacturers (2018-2024) & (K Units)
Table 16. Global Saphris (Asenapine) Sales Quantity Share by Manufacturers (2018-2024)
Table 17. Global Saphris (Asenapine) Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Saphris (Asenapine) Revenue Share by Manufacturers (2018-2024)
Table 19. Global Saphris (Asenapine) Price by Manufacturers 2018-2024 (USD/Unit)
Table 20. Global Key Players of Saphris (Asenapine), Industry Ranking, 2021 VS 2022
Table 21. Global Saphris (Asenapine) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Saphris (Asenapine) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Saphris (Asenapine) as of 2022)
Table 23. Global Key Manufacturers of Saphris (Asenapine), Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Saphris (Asenapine), Product Offered and Application
Table 25. Global Key Manufacturers of Saphris (Asenapine), Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Saphris (Asenapine) Sales Quantity by Type (2018-2024) & (K Units)
Table 28. Global Saphris (Asenapine) Sales Quantity by Type (2024-2034) & (K Units)
Table 29. Global Saphris (Asenapine) Sales Quantity Share by Type (2018-2024)
Table 30. Global Saphris (Asenapine) Sales Quantity Share by Type (2024-2034)
Table 31. Global Saphris (Asenapine) Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Saphris (Asenapine) Revenue by Type (2024-2034) & (US$ Million)
Table 33. Global Saphris (Asenapine) Revenue Share by Type (2018-2024)
Table 34. Global Saphris (Asenapine) Revenue Share by Type (2024-2034)
Table 35. Saphris (Asenapine) Price by Type (2018-2024) & (USD/Unit)
Table 36. Global Saphris (Asenapine) Price Forecast by Type (2024-2034) & (USD/Unit)
Table 37. Global Saphris (Asenapine) Sales Quantity by Application (2018-2024) & (K Units)
Table 38. Global Saphris (Asenapine) Sales Quantity by Application (2024-2034) & (K Units)
Table 39. Global Saphris (Asenapine) Sales Quantity Share by Application (2018-2024)
Table 40. Global Saphris (Asenapine) Sales Quantity Share by Application (2024-2034)
Table 41. Global Saphris (Asenapine) Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Saphris (Asenapine) Revenue by Application (2024-2034) & (US$ Million)
Table 43. Global Saphris (Asenapine) Revenue Share by Application (2018-2024)
Table 44. Global Saphris (Asenapine) Revenue Share by Application (2024-2034)
Table 45. Saphris (Asenapine) Price by Application (2018-2024) & (USD/Unit)
Table 46. Global Saphris (Asenapine) Price Forecast by Application (2024-2034) & (USD/Unit)
Table 47. North America Saphris (Asenapine) Revenue by Company (2018-2024) & (US$ Million)
Table 48. North America Saphris (Asenapine) Sales Quantity by Company (2018-2024) & (K Units)
Table 49. North America Saphris (Asenapine) Sales Quantity by Type (2018-2024) & (K Units)
Table 50. North America Saphris (Asenapine) Sales Quantity by Type (2024-2034) & (K Units)
Table 51. North America Saphris (Asenapine) Revenue by Type (2018-2024) & (US$ Million)
Table 52. North America Saphris (Asenapine) Revenue by Type (2024-2034) & (US$ Million)
Table 53. North America Saphris (Asenapine) Sales Quantity by Application (2018-2024) & (K Units)
Table 54. North America Saphris (Asenapine) Sales Quantity by Application (2024-2034) & (K Units)
Table 55. North America Saphris (Asenapine) Revenue by Application (2018-2024) & (US$ Million)
Table 56. North America Saphris (Asenapine) Revenue by Application (2024-2034) & (US$ Million)
Table 57. North America Saphris (Asenapine) Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 58. North America Saphris (Asenapine) Revenue by Country (2018-2024) & (US$ Million)
Table 59. North America Saphris (Asenapine) Revenue by Country (2024-2034) & (US$ Million)
Table 60. North America Saphris (Asenapine) Sales Quantity by Country (2018-2024) & (K Units)
Table 61. North America Saphris (Asenapine) Sales Quantity by Country (2024-2034) & (K Units)
Table 62. Europe Saphris (Asenapine) Sales Quantity by Company (2018-2024) & (K Units)
Table 63. Europe Saphris (Asenapine) Revenue by Company (2018-2024) & (US$ Million)
Table 64. Europe Saphris (Asenapine) Sales Quantity by Type (2018-2024) & (K Units)
Table 65. Europe Saphris (Asenapine) Sales Quantity by Type (2024-2034) & (K Units)
Table 66. Europe Saphris (Asenapine) Revenue by Type (2018-2024) & (US$ Million)
Table 67. Europe Saphris (Asenapine) Revenue by Type (2024-2034) & (US$ Million)
Table 68. Europe Saphris (Asenapine) Sales Quantity by Application (2018-2024) & (K Units)
Table 69. Europe Saphris (Asenapine) Sales Quantity by Application (2024-2034) & (K Units)
Table 70. Europe Saphris (Asenapine) Revenue by Application (2018-2024) & (US$ Million)
Table 71. Europe Saphris (Asenapine) Revenue by Application (2024-2034) & (US$ Million)
Table 72. Europe Saphris (Asenapine) Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 73. Europe Saphris (Asenapine) Revenue by Country (2018-2024) & (US$ Million)
Table 74. Europe Saphris (Asenapine) Revenue by Country (2024-2034) & (US$ Million)
Table 75. Europe Saphris (Asenapine) Sales Quantity by Country (2018-2024) & (K Units)
Table 76. Europe Saphris (Asenapine) Sales Quantity by Country (2024-2034) & (K Units)
Table 77. China Saphris (Asenapine) Sales Quantity by Company (2018-2024) & (K Units)
Table 78. China Saphris (Asenapine) Revenue by Company (2018-2024) & (US$ Million)
Table 79. China Saphris (Asenapine) Sales Quantity by Type (2018-2024) & (K Units)
Table 80. China Saphris (Asenapine) Sales Quantity by Type (2024-2034) & (K Units)
Table 81. China Saphris (Asenapine) Revenue by Type (2018-2024) & (US$ Million)
Table 82. China Saphris (Asenapine) Revenue by Type (2024-2034) & (US$ Million)
Table 83. China Saphris (Asenapine) Sales Quantity by Application (2018-2024) & (K Units)
Table 84. China Saphris (Asenapine) Sales Quantity by Application (2024-2034) & (K Units)
Table 85. China Saphris (Asenapine) Revenue by Application (2018-2024) & (US$ Million)
Table 86. China Saphris (Asenapine) Revenue by Application (2024-2034) & (US$ Million)
Table 87. APAC Saphris (Asenapine) Sales Quantity by Company (2018-2024) & (K Units)
Table 88. APAC Saphris (Asenapine) Revenue by Company (2018-2024) & (US$ Million)
Table 89. APAC Saphris (Asenapine) Sales Quantity by Type (2018-2024) & (K Units)
Table 90. APAC Saphris (Asenapine) Sales Quantity by Type (2024-2034) & (K Units)
Table 91. APAC Saphris (Asenapine) Revenue by Type (2018-2024) & (US$ Million)
Table 92. APAC Saphris (Asenapine) Revenue by Type (2024-2034) & (US$ Million)
Table 93. APAC Saphris (Asenapine) Sales Quantity by Application (2018-2024) & (K Units)
Table 94. APAC Saphris (Asenapine) Sales Quantity by Application (2024-2034) & (K Units)
Table 95. APAC Saphris (Asenapine) Revenue by Application (2018-2024) & (US$ Million)
Table 96. APAC Saphris (Asenapine) Revenue by Application (2024-2034) & (US$ Million)
Table 97. APAC Saphris (Asenapine) Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 98. APAC Saphris (Asenapine) Revenue by Region (2018-2024) & (US$ Million)
Table 99. APAC Saphris (Asenapine) Revenue by Region (2024-2034) & (US$ Million)
Table 100. APAC Saphris (Asenapine) Sales Quantity by Region (2018-2024) & (K Units)
Table 101. APAC Saphris (Asenapine) Sales Quantity by Region (2024-2034) & (K Units)
Table 102. Middle East, Africa and Latin America Saphris (Asenapine) Sales Quantity by Company (2018-2024) & (K Units)
Table 103. Middle East, Africa and Latin America Saphris (Asenapine) Revenue by Company (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Saphris (Asenapine) Sales Quantity by Type (2018-2024) & (K Units)
Table 105. Middle East, Africa and Latin America Saphris (Asenapine) Sales Quantity by Type (2024-2034) & (K Units)
Table 106. Middle East, Africa and Latin America Saphris (Asenapine) Revenue by Type (2018-2024) & (US$ Million)
Table 107. Middle East, Africa and Latin America Saphris (Asenapine) Revenue by Type (2024-2034) & (US$ Million)
Table 108. Middle East, Africa and Latin America Saphris (Asenapine) Sales Quantity by Application (2018-2024) & (K Units)
Table 109. Middle East, Africa and Latin America Saphris (Asenapine) Sales Quantity by Application (2024-2034) & (K Units)
Table 110. Middle East, Africa and Latin America Saphris (Asenapine) Revenue by Application (2018-2024) & (US$ Million)
Table 111. Middle East, Africa and Latin America Saphris (Asenapine) Revenue by Application (2024-2034) & (US$ Million)
Table 112. Middle East, Africa and Latin America Saphris (Asenapine) Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 113. Middle East, Africa and Latin America Saphris (Asenapine) Revenue by Country (2018-2024) & (US$ Million)
Table 114. Middle East, Africa and Latin America Saphris (Asenapine) Revenue by Country (2024-2034) & (US$ Million)
Table 115. Middle East, Africa and Latin America Saphris (Asenapine) Sales Quantity by Country (2018-2024) & (K Units)
Table 116. Middle East, Africa and Latin America Saphris (Asenapine) Sales Quantity by Country (2024-2034) & (K Units)
Table 117. Allergan plc (AbbVie Inc.) Company Information
Table 118. Allergan plc (AbbVie Inc.) Description and Overview
Table 119. Allergan plc (AbbVie Inc.) Saphris (Asenapine) Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 120. Allergan plc (AbbVie Inc.) Saphris (Asenapine) Product and Services
Table 121. Allergan plc (AbbVie Inc.) Saphris (Asenapine) SWOT Analysis
Table 122. Allergan plc (AbbVie Inc.) Recent Developments
Table 123. Merck & Co., Inc. Company Information
Table 124. Merck & Co., Inc. Description and Overview
Table 125. Merck & Co., Inc. Saphris (Asenapine) Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 126. Merck & Co., Inc. Saphris (Asenapine) Product and Services
Table 127. Merck & Co., Inc. Saphris (Asenapine) SWOT Analysis
Table 128. Merck & Co., Inc. Recent Developments
Table 129. Actavis Generics (Teva) Company Information
Table 130. Actavis Generics (Teva) Description and Overview
Table 131. Actavis Generics (Teva) Saphris (Asenapine) Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 132. Actavis Generics (Teva) Saphris (Asenapine) Product and Services
Table 133. Actavis Generics (Teva) Saphris (Asenapine) SWOT Analysis
Table 134. Actavis Generics (Teva) Recent Developments
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Saphris (Asenapine) Distributors List
Table 138. Saphris (Asenapine) Customers List
Table 139. Saphris (Asenapine) Market Trends
Table 140. Saphris (Asenapine) Market Drivers
Table 141. Saphris (Asenapine) Market Challenges
Table 142. Saphris (Asenapine) Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Saphris (Asenapine) Product Picture
Figure 2. Global Saphris (Asenapine) Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Saphris (Asenapine) Market Share by Type in 2022 & 2034
Figure 4. 5 mg Product Picture
Figure 5. 10 mg Product Picture
Figure 6. Global Saphris (Asenapine) Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 7. Global Saphris (Asenapine) Market Share by Application in 2022 & 2034
Figure 8. Schizophrenia
Figure 9. Acute Mania
Figure 10. Others
Figure 11. Saphris (Asenapine) Report Years Considered
Figure 12. Global Saphris (Asenapine) Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 13. Global Saphris (Asenapine) Revenue 2018-2034 (US$ Million)
Figure 14. Global Saphris (Asenapine) Revenue Market Share by Region in Percentage: 2022 Versus 2034
Figure 15. Global Saphris (Asenapine) Sales Quantity 2018-2034 (K Units)
Figure 16. Global Saphris (Asenapine) Sales Quantity Market Share by Region (2018-2024)
Figure 17. Global Saphris (Asenapine) Sales Quantity Market Share by Region (2024-2034)
Figure 18. North America Saphris (Asenapine) Sales Quantity YoY (2018-2034) & (K Units)
Figure 19. North America Saphris (Asenapine) Revenue YoY (2018-2034) & (US$ Million)
Figure 20. Europe Saphris (Asenapine) Sales Quantity YoY (2018-2034) & (K Units)
Figure 21. Europe Saphris (Asenapine) Revenue YoY (2018-2034) & (US$ Million)
Figure 22. China Saphris (Asenapine) Sales Quantity YoY (2018-2034) & (K Units)
Figure 23. China Saphris (Asenapine) Revenue YoY (2018-2034) & (US$ Million)
Figure 24. APAC Saphris (Asenapine) Sales Quantity YoY (2018-2034) & (K Units)
Figure 25. APAC Saphris (Asenapine) Revenue YoY (2018-2034) & (US$ Million)
Figure 26. Middle East, Africa and Latin America Saphris (Asenapine) Sales Quantity YoY (2018-2034) & (K Units)
Figure 27. Middle East, Africa and Latin America Saphris (Asenapine) Revenue YoY (2018-2034) & (US$ Million)
Figure 28. The Top 10 and Top 5 Players Market Share by Saphris (Asenapine) Sales Quantity in 2022
Figure 29. The Top 10 and Top 5 Players Market Share by Saphris (Asenapine) Revenue in 2022
Figure 30. Saphris (Asenapine) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 31. Global Saphris (Asenapine) Sales Quantity Market Share by Type (2018-2034)
Figure 32. Global Saphris (Asenapine) Revenue Market Share by Type (2018-2034)
Figure 33. Global Saphris (Asenapine) Sales Quantity Market Share by Application (2018-2034)
Figure 34. Global Saphris (Asenapine) Revenue Market Share by Application (2018-2034)
Figure 35. North America Saphris (Asenapine) Revenue Market Share by Company in 2022
Figure 36. North America Saphris (Asenapine) Sales Quantity Market Share by Company in 2022
Figure 37. North America Saphris (Asenapine) Sales Quantity Market Share by Type (2018-2034)
Figure 38. North America Saphris (Asenapine) Revenue Market Share by Type (2018-2034)
Figure 39. North America Saphris (Asenapine) Sales Quantity Market Share by Application (2018-2034)
Figure 40. North America Saphris (Asenapine) Revenue Market Share by Application (2018-2034)
Figure 41. North America Saphris (Asenapine) Revenue Share by Country (2018-2034)
Figure 42. North America Saphris (Asenapine) Sales Quantity Share by Country (2018-2034)
Figure 43. U.S. Saphris (Asenapine) Revenue (2018-2034) & (US$ Million)
Figure 44. Canada Saphris (Asenapine) Revenue (2018-2034) & (US$ Million)
Figure 45. Europe Saphris (Asenapine) Sales Quantity Market Share by Company in 2022
Figure 46. Europe Saphris (Asenapine) Revenue Market Share by Company in 2022
Figure 47. Europe Saphris (Asenapine) Sales Quantity Market Share by Type (2018-2034)
Figure 48. Europe Saphris (Asenapine) Revenue Market Share by Type (2018-2034)
Figure 49. Europe Saphris (Asenapine) Sales Quantity Market Share by Application (2018-2034)
Figure 50. Europe Saphris (Asenapine) Revenue Market Share by Application (2018-2034)
Figure 51. Europe Saphris (Asenapine) Revenue Share by Country (2018-2034)
Figure 52. Europe Saphris (Asenapine) Sales Quantity Share by Country (2018-2034)
Figure 53. Germany Saphris (Asenapine) Revenue (2018-2034) & (US$ Million)
Figure 54. France Saphris (Asenapine) Revenue (2018-2034) & (US$ Million)
Figure 55. U.K. Saphris (Asenapine) Revenue (2018-2034) & (US$ Million)
Figure 56. Italy Saphris (Asenapine) Revenue (2018-2034) & (US$ Million)
Figure 57. Russia Saphris (Asenapine) Revenue (2018-2034) & (US$ Million)
Figure 58. China Saphris (Asenapine) Sales Quantity Market Share by Company in 2022
Figure 59. China Saphris (Asenapine) Revenue Market Share by Company in 2022
Figure 60. China Saphris (Asenapine) Sales Quantity Market Share by Type (2018-2034)
Figure 61. China Saphris (Asenapine) Revenue Market Share by Type (2018-2034)
Figure 62. China Saphris (Asenapine) Sales Quantity Market Share by Application (2018-2034)
Figure 63. China Saphris (Asenapine) Revenue Market Share by Application (2018-2034)
Figure 64. APAC Saphris (Asenapine) Sales Quantity Market Share by Company in 2022
Figure 65. APAC Saphris (Asenapine) Revenue Market Share by Company in 2022
Figure 66. APAC Saphris (Asenapine) Sales Quantity Market Share by Type (2018-2034)
Figure 67. APAC Saphris (Asenapine) Revenue Market Share by Type (2018-2034)
Figure 68. APAC Saphris (Asenapine) Sales Quantity Market Share by Application (2018-2034)
Figure 69. APAC Saphris (Asenapine) Revenue Market Share by Application (2018-2034)
Figure 70. APAC Saphris (Asenapine) Revenue Share by Region (2018-2034)
Figure 71. APAC Saphris (Asenapine) Sales Quantity Share by Region (2018-2034)
Figure 72. Japan Saphris (Asenapine) Revenue (2018-2034) & (US$ Million)
Figure 73. South Korea Saphris (Asenapine) Revenue (2018-2034) & (US$ Million)
Figure 74. China Taiwan Saphris (Asenapine) Revenue (2018-2034) & (US$ Million)
Figure 75. Southeast Asia Saphris (Asenapine) Revenue (2018-2034) & (US$ Million)
Figure 76. India Saphris (Asenapine) Revenue (2018-2034) & (US$ Million)
Figure 77. Middle East, Africa and Latin America Saphris (Asenapine) Sales Quantity Market Share by Company in 2022
Figure 78. Middle East, Africa and Latin America Saphris (Asenapine) Revenue Market Share by Company in 2022
Figure 79. Middle East, Africa and Latin America Saphris (Asenapine) Sales Quantity Market Share by Type (2018-2034)
Figure 80. Middle East, Africa and Latin America Saphris (Asenapine) Revenue Market Share by Type (2018-2034)
Figure 81. Middle East, Africa and Latin America Saphris (Asenapine) Sales Quantity Market Share by Application (2018-2034)
Figure 82. Middle East, Africa and Latin America Saphris (Asenapine) Revenue Market Share by Application (2018-2034)
Figure 83. Middle East, Africa and Latin America Saphris (Asenapine) Sales Quantity Share by Country (2018-2034)
Figure 84. Middle East, Africa and Latin America Saphris (Asenapine) Revenue Share by Country (2018-2034)
Figure 85. Brazil Saphris (Asenapine) Revenue (2018-2034) & (US$ Million)
Figure 86. Mexico Saphris (Asenapine) Revenue (2018-2034) & (US$ Million)
Figure 87. Turkey Saphris (Asenapine) Revenue (2018-2034) & (US$ Million)
Figure 88. Israel Saphris (Asenapine) Revenue (2018-2034) & (US$ Million)
Figure 89. GCC Countries Saphris (Asenapine) Revenue (2018-2034) & (US$ Million)
Figure 90. Saphris (Asenapine) Value Chain
Figure 91. Saphris (Asenapine) Production Process
Figure 92. Channels of Distribution (Direct Vs Distribution)
Figure 93. Distributors Profiles
Figure 94. Bottom-up and Top-down Approaches for This Report
Figure 95. Data Triangulation
Figure 96. Key Executives Interviewed